Early Postoperative Cardiac Complications Following Heart Transplantation

Post-Heart Transplantation Complications

Authors

  • Sohrab Negargar Cardiovascular Research Center of Tabriz University of Medical Sciences, Tabriz, Iran
  • Sahar Sadeghi Cardiovascular Research Center of Tabriz University of Medical Sciences, Tabriz, Iran

DOI:

https://doi.org/10.31661/gmj.v12i.2701

Keywords:

Postoperative Complication, Heart Transplantation, Heart Failure

Abstract

Cardiovascular disorders remain the leading cause of death around the world. Heart transplan-tation is considered the only therapeutic choice defined as the gold standard strategy to manage end-stage heart failure. Nevertheless, the remaining postoperative complications compromise both the survival rate and quality of life in heart transplantation recipients. The present study aimed to review the current findings concerning the main early complications after heart trans-plantation, reliable predictors, diagnostic approaches, novel surgical techniques, and manage-ment strategies. The results demonstrated that significant advances in immunosuppressive phar-maceuticals, determining appropriate policies for donor acceptance, pre- and post-operative treatment/care, selection of the most compatible donor with the recipient, and the suggestion of novel diagnostic and surgical techniques over the past decade had dropped the mortality and morbidity rates early after transplantation. However, marrhythmia, atrial flutter, atrial fibrilla-tion, deep sternal wound infection along with other sites infections, low cardiac output syn-drome, acute graft dysfunction, pericardial effusion, constrictive pericarditis, and acute cellular rejection could be considered as the major early complications following heart transplanta-tions that pivotally require further investigations.

References

Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health. 2021;21(1):1-12.

https://doi.org/10.1186/s12889-021-10429-0

Yurievich AA, Viktorovna SO, Sergeevich R, Ivanovich KD, Vladimirovich RO, Mikhaylovich NA et al. Clinical Management of Cardiovascular Care on the Basis of Big Data: Electronic Medical Records. J Med Chem Sci. 2021;4(4):395-403.

Khalil Arjmandi R, Asharein MR. Case Study of Femoral and Radial Angiography in Cardiovascular Patients. Chem. Methodol.5(1):1-10.

Şahin B, İlgün G. Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries. Health Soc Care Community. 2022;30(1):73-80.

https://doi.org/10.1111/hsc.13156

Bahaoddini A, Alsadat Miryousefiata F. Therapeutic Effects of Hydro-alcoholic Extract of Papaver Rhoeas on Cardiovascular side effect of MIA Induced Osteoarthritis in male Rat. Prog chem biochem res. 2020;3(4):340-9.

Hudiyawati D, Ainunnisa K, Riskamala G. Self-care and its related factors among patients with congestive heart failure in Surakarta, Indonesia. J Med Chem Sci. 2021;4(4):364-73.

Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716-99.

https://doi.org/10.1093/eurheartj/ehab892

Safapoor S, Yazdani H, Shahabi P. A Review on Synthesis and Applications of Statin Family Drugs as a New Generations of Anti-Blood Medicines. J chem rev. 2(1):1-27.

https://doi.org/10.33945/SAMI/JCR.2020.1.1

Mannoh I, Hussien M, Commodore-Mensah Y, Michos ED. Impact of social determinants of health on cardiovascular disease prevention. Curr Opin Cardiol. 2021;36(5):572-9.

https://doi.org/10.1097/HCO.0000000000000893

Ndejjo R, Musinguzi G, Nuwaha F, Bastiaens H, Wanyenze RK. Understanding factors influencing uptake of healthy lifestyle practices among adults following a community cardiovascular disease prevention programme in Mukono and Buikwe districts in Uganda: A qualitative study. PLoS One. 2022;17(2):e0263867.

https://doi.org/10.1371/journal.pone.0263867

Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL et al. Ten things to know about ten cardiovascular disease risk factors. AJPC. 2021;5:100149.

https://doi.org/10.1016/j.ajpc.2021.100149

Pederiva C, Capra ME, Biasucci G, Banderali G, Fabrizi E, Gazzotti M et al. Lipoprotein (a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group Atherosclerosis. 2022;349:233-9.

https://doi.org/10.1016/j.atherosclerosis.2022.04.021

Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56.

https://doi.org/10.1002/ejhf.1858

Braunwald E. The war against heart failure: the Lancet lecture. The Lancet. 2015;385(9970):812-24.

https://doi.org/10.1016/S0140-6736(14)61889-4

Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. Heart Fail. 2020;8(7):523-36.

https://doi.org/10.1016/j.jchf.2020.01.014

Yancy CW, Januzzi JL, Allen LA, Butler J, Davis LL, Fonarow GC et al. 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018;71(2):201-30.

https://doi.org/10.1016/j.jacc.2017.11.025

Breathett K, Yee E, Pool N, Hebdon M, Crist JD, Yee RH et al. Association of gender and race with allocation of advanced heart failure therapies. JAMA network open. 2020;3(7):e2011044-e.

https://doi.org/10.1001/jamanetworkopen.2020.11044

Losman JG, Barnard CN, Bartley TD. Hemodynamic evaluation of left ventricular bypass with a homologous cardiac graft. J Thorac Cardiovasc. 1977;74(5):695-708.

https://doi.org/10.1016/S0022-5223(19)41205-1

Mangini S, Alves BR, Silvestre OM, Pires PV, Pires LJT, Curiati MNC et al. Heart transplantation. Einstein (Sao Paulo). 2015;13:310-8.

https://doi.org/10.1590/S1679-45082015RW3154

Colombo D, Ammirati E. Cyclosporine in transplantation-a history of converging timelines. J Biol Regul Homeost Agents. 2011;25(4):493-504.

Smith KB, Potters TO, Zenarosa GL. Pretransplant survival of patients with end-stage heart failure under competing risks. PLoS One. 2022;17(8):e0273100.

https://doi.org/10.1371/journal.pone.0273100

Hernandez GA, Lemor A, Clark D, Blumer V, Burstein D, Byrne R et al. Heart transplantation and in-hospital outcomes in adult congenital heart disease patients with Fontan: A decade nationwide analysis from 2004 to 2014. J Card Surg. 2020;35(3):603-8.

https://doi.org/10.1111/jocs.14430

Sobrino-Márquez J, Grande-Trillo A, Cantero-Pérez E, Rangel-Sousa D, Lage-Galle E, Adsuar-Gómez A,. Prognostic value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure Transplant. Proc. 2018: Elsevier.

https://doi.org/10.1016/j.transproceed.2017.11.060

Aiad N, Elnabawai YA, Li B, Narula N, Gidea C, Katz SD et al. Missed opportunities in identifying cardiomyopathy aetiology prior to advanced heart failure therapy. Heart Lung Circ. 2022;31(6):815-21.

https://doi.org/10.1016/j.hlc.2021.12.014

Urschel S, Ballweg JA, Cantor RS, Koehl DA, Reinhardt Z, Zuckerman WA et al. Clinical outcomes of children receiving ABO-incompatible versus ABO-compatible heart transplantation: a multicentre cohort study. Lancet Child Adolesc. 2021;5(5):341-9.

https://doi.org/10.1016/S2352-4642(21)00023-7

Kim I-C, Youn J-C, Kobashigawa JA. The past, present and future of heart transplantation. Korean Circ J. 2018;48(7):565-90.

https://doi.org/10.4070/kcj.2018.0189

Rahm AK, Helmschrott M, Darche FF, Thomas D, Bruckner T, Ehlermann P et al. Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survival. ESC Heart Failure. 2021;8(5):3737-47.

https://doi.org/10.1002/ehf2.13494

Joglar JA, Wan EY, Chung MK, Gutierrez A, Slaughter MS, Bateson BP et al. Management of arrhythmias after heart transplant: current state and considerations for future research. Circ Arrhythm Electrophysiol. 2021;14(3):e007954.

https://doi.org/10.1161/CIRCEP.120.007954

Rivinius R, Helmschrott M, Rahm A-K, Darche FF, Thomas D, Bruckner T et al. Risk factors and survival of patients with permanent pacemaker implantation after heart transplantation. J Thorac Dis. 2019;11(12):5440.

https://doi.org/10.21037/jtd.2019.11.45

Magnano AR, Garan H. Catheter ablation of supraventricular tachycardia in the transplanted heart: a case series and literature review. Pacing Clin Electrophysiol. 2003;26(9):1878-86.

https://doi.org/10.1046/j.1460-9592.2003.00284.x

Drogalis-Kim DE, Gallotti RG, Blais BA, Perens G, Moore JP. Clinical and electrophysiological properties of atrial tachycardia after pediatric heart transplantation. Pacing Clin Electrophysiol. 2018;41(9):1093-100.

https://doi.org/10.1111/pace.13415

Nof E, Stevenson WG, Epstein LM, Tedrow UB, Koplan BA. Catheter ablation of atrial arrhythmias after cardiac transplantation: Findings at EP study utility of 3-D mapping and outcomes. J Cardiovasc Electrophysiol. 2013;24(5):498-502.

https://doi.org/10.1111/jce.12078

Cantillon DJ. Atrial tachyarrhythmias after cardiac transplantation. Card Electrophysiol Clin. 2012;4(3):455-60.

https://doi.org/10.1016/j.ccep.2012.05.006

Elsik M, Teh A, Ling L-H, Virdee M, Parameshwar J, Fynn SP et al. Supraventricular arrhythmias late after orthotopic cardiac transplantation: electrocardiographic and electrophysiological characterization and radiofrequency ablation. Europace. 2012;14(10):1498-505.

https://doi.org/10.1093/europace/eus092

Noworolski R, Przybylowski P, Majewski J, Sadowski J, Lelakowski J,. Early and late indications for implantation of cardiac pacemakers in patients after heart transplantation: a single-center experience. Transplant. Proc.; 2011: Elsevier.

https://doi.org/10.1016/j.transproceed.2011.08.039

Rubin GA, Wan EY. Leadless Pacemakers after Cardiac Transplantation. ASAIO J. 2020;66(3):e57.

https://doi.org/10.1097/MAT.0000000000001114

Anselmino M, Matta M, Saglietto A, Gallo C, Gaita F, Marchetto G et al. Long-term atrial arrhythmias incidence after heart transplantation. Int J Cardiol. 2020;311:58-63.

https://doi.org/10.1016/j.ijcard.2020.04.019

Taylor ME, McDiarmid AK, Matthews IG, Kakarla J, McComb JM, Parry G et al. A retrospective evaluation of catheter ablation in atrial flutter post cardiac transplantation. Clin Transplant. 2021;35(10):e14429.

https://doi.org/10.1111/ctr.14429

Rodriguez-Entem F, Exposito V, Gonzalez-Enriquez S, Garcia-Camarero T, Olalla J,. Atrial flutter after heart transplantation: mechanism and catheter ablation. Transplant. Proc.; 2010: Elsevier.

https://doi.org/10.1016/j.transproceed.2010.04.067

Sohns C, Marrouche NF, Costard-Jäckle A, Sossalla S, Bergau L, Schramm R et al. Catheter ablation for atrial fibrillation in patients with end-stage heart failure and eligibility for heart transplantation. ESC Heart Failure. 2021;8(2):1666-74.

https://doi.org/10.1002/ehf2.13150

Ermis C, Zadeii G, Zhu AX, Fabian W, Collins J, Lurie KG et al. Improved Survival of Cardiac Transplantation Candidates with Implantable Cardioverter Defibrillator Therapy: Role of Beta-Blocker or Amiodarone Treatment. J Cardiovasc Electrophysiol. 2003;14(6):578-83.

https://doi.org/10.1046/j.1540-8167.2003.02590.x

Sakamoto S-I, Ishii Y, Otsuka T, Mitsuno M, Shimokawa T, Isomura T et al. Multicenter randomized study evaluating the outcome of ganglionated plexi ablation in maze procedure. Gen Thorac Cardiovasc Surg. 2022:1-8.

https://doi.org/10.1007/s11748-022-01820-8

Suwalski G, Suwalski P. Successful surgical ablation of atrial fibrillation does not disturb long-term sinus rhythm variability. Interact Cardiovasc Thorac Surg. 2018;27(4):520-4.

https://doi.org/10.1093/icvts/ivy117

Cohn WE, Gregoric ID, Radovancevic B, Wolf RK, Frazier O. Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Cardiothorac Surg. 2008;85(1):56-8.

https://doi.org/10.1016/j.athoracsur.2007.07.037

Barnea Y, Lerner A, Aizic A, Navon-Venezia S, Rachi E, Dunne MW et al. Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis. J Antimicrob Chemother. 2016;71(2):460-3.

https://doi.org/10.1093/jac/dkv357

Singh K, Anderson E, Harper JG,. Overview and management of sternal wound infection. Seminars in plastic surgery. 2011;25(11):25-33.

https://doi.org/10.1055/s-0031-1275168

Fleck T, Moidl R, Grimm M, Wolner E, Zuckermann A. Vacuum assisted closure therapy for the treatment of sternal wound infections after heart transplantation: preliminary results. Zentralbl Chir. 2007;132(2):138-41.

https://doi.org/10.1055/s-2007-960650

Carrier M, Perrault LP, Pellerin M, Marchand R, Auger P, Pelletier GB et al. Sternal wound infection after heart transplantation: incidence and results with aggressive surgical treatment. Ann Cardiothorac Surg. 2001;72(3):719-23.

https://doi.org/10.1016/S0003-4975(01)02824-7

Kohli M, Yuan L, Escobar M, David T, Gillis G, Garcia M et al. A risk index for sternal surgical wound infection after cardiovascular surgery. Infect Control Hosp Epidemiol. 2003;24(1):17-25.

https://doi.org/10.1086/502110

Akar AR, Sarıcaoğlu MC, Çakıcı M, Inan MB. Candida mediastinitis: alarming clinical entity from a case-matched comparative study. Oxford University Press. 2022;61(3): 531-2.

https://doi.org/10.1093/ejcts/ezac001

Hamaguchi R, Shekar PS, Johnson JA, Orgill DP. Current management of sternal wounds. Plast Reconstr Surg. 2021;148(6):1012e-25e.

https://doi.org/10.1097/PRS.0000000000008510

Filsoufi F, Rahmanian PB, Castillo JG, Pinney S, Broumand SR, Adams DH. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. The J Heart Lung Transplant. 2007;26(11):1084-90.

https://doi.org/10.1016/j.healun.2007.07.036

Wallen TJ, Habertheuer A, Gottret JP, Kramer M, Abbas Z, Siki M et al. Sternal wound complications in patients undergoing orthotopic heart transplantation. J Card Surg. 2019;34(4):186-9.

https://doi.org/10.1111/jocs.14003

O'Keeffe N, Concannon E, Stanley A, Dockery P, McInerney N, Kelly JL. Cadaveric evaluation of sternal reconstruction using the pectoralis muscle flap. ANZ J Surg. 2019;89(7-8):945-9.

https://doi.org/10.1111/ans.15268

Fleck T, Moidl R, Grimm M, Wolner E, Zuckermann A. VAC-Therapie zur Behandlung von sternalen Wundinfektionen nach Herztransplantation: Erste Ergebnisse. Zentralbl Chir. 2007;132(02):138-41.

https://doi.org/10.1055/s-2007-960650

Eifert S, Kronschnabl S, Kaczmarek I, Reichart B, Vicol C. Omental flap for recurrent deep sternal wound infection and mediastinitis after cardiac surgery. Thorac Cardiovasc Surg. 2007;55(06):371-4.

https://doi.org/10.1055/s-2007-965305

Boulemden A, Speggiorin S, Pelella G, Lotto AA. Use of an extracellular matrix patch for sternal wound dehiscence after cardiac surgery in a neonate. Tex Heart Inst J. 2018;45(3):176-8.

https://doi.org/10.14503/THIJ-17-6239

Yu J, Wu R, Xiong B, Huang Z, Li H,. Metagenomic Next-Generation Sequencing in the Diagnosis of Deep Sternal Wound Infection After Cardiac Transplantation: A Case Report and Literature Review. Heart Surg Forum. 2021;24(6):1015-1017.

https://doi.org/10.1532/hsf.4169

Lin C-H, Lin C-H, Tsai F-C, Lin P-J. Unilateral Pedicled Pectoralis Major Harvested by Endoscopic-Assisted Method Achieves Adequate Management of Sternal Infection and Mediastinitis. J Reconstr Microsurg. 2019;35(09):705-12.

https://doi.org/10.1055/s-0039-1695089

Cove ME, Spelman DW, MacLaren G. Infectious complications of cardiac surgery: a clinical review. J Cardiothorac Vasc Anesth. 2012;26(6):1094-100.

https://doi.org/10.1053/j.jvca.2012.04.021

Gómez-López R, Barge-Caballero E, Fernández-Ugidos P, Paniagua-Martin MJ, Barge-Caballero G, Couto-Mallón D et al. In-Hospital Post-Operative Infection after Heart Transplantation: Epidemiology, Clinical Management, and Outcome. Surg Infect (Larchmt). 2020;21(2):179-91.

https://doi.org/10.1089/sur.2019.073

Shultes KC, Shuster JE, Micek S, Vader JM, Balsara K, Itoh A et al. Outcomes and predictors of early infection after heart transplantation. Surg Infect (Larchmt). 2018;19(5):516-22.

https://doi.org/10.1089/sur.2017.295

Bhatt PJ, Ali M, Rana M, Patel G, Sullivan T, Murphy J et al. Infections due to multidrug-resistant organisms following heart transplantation: Epidemiology, microbiology, and outcomes. Transpl Infect Dis. 2020;22(1):e13215.

https://doi.org/10.1111/tid.13215

Rostad CA, Wehrheim K, Kirklin JK, Naftel D, Pruitt E, Hoffman TM et al. Bacterial infections after pediatric heart transplantation: epidemiology, risk factors and outcomes. J Heart Lung Transplant. 2017;36(9):996-1003.

https://doi.org/10.1016/j.healun.2017.05.009

Duero Posada JG, Moayedi Y, Alhussein M, Bunce PE, Yau TM, Ross HJ. Early pneumopericardium after heart transplantation. Transpl Infect Dis. 2018;20(1):e12800.

https://doi.org/10.1111/tid.12800

Angleitner P, Arnoldner MA, Zuckermann AO, Aliabadi-Zuckermann AZ. Severe gastroparesis after orthotopic heart transplantation. Eur J Cardiothorac Surg. 2021;59(3):717-9.

https://doi.org/10.1093/ejcts/ezaa309

Roest S, Brugts JJ, van Kampen JJ, Jan H, Constantinescu AA, Caliskan K et al. COVID-19-related myocarditis post-heart transplantation. Int J Infect Dis. 2021;107:34-6.

https://doi.org/10.1016/j.ijid.2021.04.013

Boutolleau D, Coutance G, Désiré E, Bouglé A, Bréchot N, Leprince P et al. Association between cytomegalovirus infection and allograft rejection in a large contemporary cohort of heart transplant recipients. Transpl Infect Dis. 2021;23(4):e13569.

https://doi.org/10.1111/tid.13569

Yetmar ZA, Lahr B, Brumble L, Gea Banacloche J, Steidley DE, Kushwaha S et al. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients. Transpl Infect Dis. 2021;23(5):e13714.

https://doi.org/10.1111/tid.13714

de Santis A, Gilberto GM, Mangini S, Megale AB, Gaiotto FA, Terra RM et al. A medical epopee: recurrent fungal endocarditis, heart transplantation and chylopericardium. BMC Cardiovasc Disord. 2020;20(1):1-6.

https://doi.org/10.1186/s12872-020-01755-z

Multani A, Moayedi Y, Puing A, Henricksen E, Garvert DW, Gomez CA et al. Recent trends of infectious complications following heart transplantation. Transplantation. 2020;104(10):e284-e94.

https://doi.org/10.1097/TP.0000000000003307

Foroutan F, Malik A, Nelson LMS, Steve C-PF, Guyatt G, Gustafsson F et al. Association between routine measures of graft function and mortality in heart transplant recipients. Heart. 2022;108(4):307-11.

https://doi.org/10.1136/heartjnl-2020-318721

Lozano-Edo S, Sánchez-Lázaro I, Portolés M, Roselló-Lletí E, Tarazón E, Arnau-Vives MA et al. Plasma levels of SERCA2a as a noninvasive biomarker of primary graft dysfunction after heart transplantation. Transplantation. 2022;106(4):887-93.

https://doi.org/10.1097/TP.0000000000003798

Jahania MS, Mullett TW, Sanchez JA, Narayan P, Lasley RD, Mentzer Jr RM. Acute allograft failure in thoracic organ transplantation. J Card Surg. 2000;15(2):122-8.

Fujita T, Toda K, Yanase M, Seguchi O, Murata Y, Ishibashi-Ueda H et al. Risk factors for post-transplant low output syndrome. Eur J Cardiothorac Surg. 2012;42(3):551-6.

https://doi.org/10.1093/ejcts/ezs032

Fujino T, Kinugawa K, Nitta D, Imamura T, Maki H, Amiya E et al. Donor age is a predictor of early low output after heart transplantation. J Cardiol. 2016;67(5):477-82.

https://doi.org/10.1016/j.jjcc.2015.07.007

Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114(1_supplement):I-27-I-32.

https://doi.org/10.1161/CIRCULATIONAHA.105.000737

Luckraz H, Goddard M, Charman SC, Wallwork J, Parameshwar J, Large SR. Early mortality after cardiac transplantation: should we do better? J Heart Lung Transplant. 2005;24(4):401-5.

https://doi.org/10.1016/j.healun.2004.02.013

Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC, Keck BM et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant. 2005;24(8):945-55.

https://doi.org/10.1016/j.healun.2005.05.018

Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transplant International. 2008;21(2):113-25.

https://doi.org/10.1111/j.1432-2277.2007.00603.x

Blumer V, Marbach J, Veasey T, Kanwar M. Role of medical management of cardiogenic shock in the era of mechanical circulatory support. Curr Opin Cardiol. 2022;37(3):250-60.

https://doi.org/10.1097/HCO.0000000000000966

Romanowski B, Pharm D. Congenital heart defects, heart surgeries, low cardiac output syndrome. Cardiology and Nephrology. 2020:7-33.

Pollock KA, McMillan Z, Gert Diederick Pretorius V, Cronin B. Low cardiac output after orthotopic heart transplant secondary to large inferior vena cava thrombus after prothrombin complex: a case report. A&A Practice. 2017;8(3):43-6.

https://doi.org/10.1213/XAA.0000000000000418

Lim HS, Ranasinghe A, Chue C, Quinn D, Mukadam M, Mascaro J. Cardiac power output index and severe primary graft dysfunction after heart transplantation. J Cardiothorac Vasc Anesth. 2021;35(2):398-403.

https://doi.org/10.1053/j.jvca.2020.07.020

Jha AK, Hittalmani SK. Septic Shock in Low-Cardiac-Output Patients With Heart and Lung Transplantation: Diagnosis and Management Dilemma. J Cardiothorac Vasc Anesth. 2017;31(4):1389-96.

https://doi.org/10.1053/j.jvca.2016.11.003

Marasco SF, Vale M, Pellegrino V, Preovolos A, Leet A, Kras A et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann Cardiothorac Surg. 2010;90(5):1541-6.

https://doi.org/10.1016/j.athoracsur.2010.05.066

Singh TP, Profita EL, Rycus P, Thiagarajan R, Gauvreau K. Risk factors for severe primary graft dysfunction in infants following heart transplant. Am Heart J. 2021;10(13):e021082.

https://doi.org/10.1161/JAHA.121.021082

McAree D, Yu S, Schumacher KR, Lowery R, McCormick AD, Thorsson T et al. Predictors and clinical significance of pericardial effusions after pediatric heart transplantation. Pediatr Transplant. 2022;26(1):e14153.

https://doi.org/10.1111/petr.14153

Menu E, Kabtani J, Roubin J, Ranque S, L'Ollivier C. Pericardial Effusion Due to Trichosporon japonicum: A Case Report and Review of the Literature. Pathogens. 2022;11(5):598.

https://doi.org/10.3390/pathogens11050598

Almenar L, Osa A, Martinez-Dolz L, Miró V, Quesada T, Cano O et al,. Echocardiographic evaluation of the evolutionary changes after heart transplantation. Transplant Proc. 2006;38(8):2575-2576.

https://doi.org/10.1016/j.transproceed.2006.08.033

Fröhlich GM, Keller P, Schmid F, Wolfrum M, Osranek M, Falk C et al. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur Heart J. 2013;34(19):1414-23.

https://doi.org/10.1093/eurheartj/eht006

Stämpfli SF, Özkartal T, Hagenbuch N, Bernhart S, Flammer AJ, Vecchiati A et al. Pericardial effusion unrelated to surgery is a predictor of mortality in heart transplant patients. Cardiol J. 2018;25(6):714-21.

Essandoh M. Atypical Presentation of a Large Pericardial Effusion after Heart Transplantation in a Patient with Dilated Cardiomyopathy. J Cardiothorac Vasc Anesth. 2018;32(4):e84.

https://doi.org/10.1053/j.jvca.2018.01.008

Urbanowicz T, Staburzyńska-Migaj E, Pawłowska M, Żabicki B, Michalak M, Filipiak M et al. EuroSCORE is a predictor of postoperative pericardial effusion following heart transplantation. Ann Transplant. 2015;20:193-7.

https://doi.org/10.12659/AOT.892582

Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M, Argulian E. Natriuretic peptides to differentiate constrictive pericarditis and restrictive cardiomyopathy: A systematic review and meta-analysis. Clin Cardiol. 2022;45(3):251-7.

https://doi.org/10.1002/clc.23772

Sohal S, Mathai SV, Lipat K, Kaur A, Visveswaran G, Cohen M et al. Multimodality Imaging of Constrictive Pericarditis: Pathophysiology and New Concepts. Curr Cardiol Rep. 2022:1-15.

https://doi.org/10.1007/s11886-022-01758-6

Ismail TF. Acute pericarditis: update on diagnosis and management. Clin Med (Northfield Il). 2020;20(1):48.

https://doi.org/10.7861/clinmed.cme.20.1.4

Welch TD. Constrictive pericarditis: diagnosis, management and clinical outcomes. Heart. 2018;104(9):725-31.

https://doi.org/10.1136/heartjnl-2017-311683

Tchana-Sato V, Ancion A, Ansart F, Defraigne JO. Constrictive pericarditis after heart transplantation: a case report. Eur Heart J Case Rep. 2020;4:1-6.

https://doi.org/10.1093/ehjcr/ytaa240

Bansal R, Perez L, Razzouk A, Wang N, Bailey L. Pericardial constriction after cardiac transplantation. J Heart Lung Transplant. 2010;29(3):371-7.

https://doi.org/10.1016/j.healun.2009.07.015

Aliabadi-Zuckermann AZ, Gökler J, Kaider A, Riebandt J, Moayedifar R, Osorio E et al. Donor heart selection and outcomes: An analysis of over 2,000 cases. J Heart Lung Transplant. 2018;37(8):976-84.

https://doi.org/10.1016/j.healun.2018.04.014

Katz M, Freimark D, Raichlin E, Har-Zahav Y, Arad M, Kassif Y et al. Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management Tertiary center experience: The Sheba Heart Transplantation Registry. Clin Transplant. 2017;31(10):e13063.

https://doi.org/10.1111/ctr.13063

Almenar L, Garcı́a-Palomar C, Martı́nez-Dolz L, Chamorro C, Moro J, Zorio E et al. Influence of induction therapy on rejection and survival in heart transplantation. Transplant Proc. 2005: Elsevier.

https://doi.org/10.1016/j.transproceed.2005.09.154

Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D, Hsich E et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1056-66.

https://doi.org/10.1016/j.healun.2019.08.004

Pérez-Carrillo L, Sánchez-Lázaro I, Triviño JC, Feijóo-Bandín S, Lago F, González-Juanatey JR et al. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients. J Heart Lung Transplant. 2022;41(2):137-47.

https://doi.org/10.1016/j.healun.2021.10.004

Billingham M, CARY NB, Hammond M, Kemnitz J, Marboe C, McCallister H. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. Heart Transplant. 1990;9(6):587-93.

Alexander RT, Steenbergen C. Cause of death and sudden cardiac death after heart transplantation: an autopsy study. Am J Clin Pathol. 2003;119(5):740-8.

https://doi.org/10.1309/713JVR58EF916DN5

Lee JM, Choi KH, Choi J-O, Shin D, Park Y, Kim J et al. Coronary microcirculatory dysfunction and acute cellular rejection after heart transplantation. Circulation. 2021;144(18):1459-72.

https://doi.org/10.1161/CIRCULATIONAHA.121.056158

Ram E, Klempfner R, Peled A, Kassif Y, Sternik L, Lavee J et al. Weight gain post-heart transplantation is associated with an increased risk for allograft vasculopathy and rejection. Clin Transplant. 2021;35(3):e14187.

https://doi.org/10.1111/ctr.14187

Chin C, Naftel DC, Singh TP, Blume ED, Luikart H, Bernstein D et al. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant. 2004;23(2):178-85.

https://doi.org/10.1016/S1053-2498(03)00059-7

Husain N, Watanabe K, Berhane H, Gupta A, Markl M, Rigsby CK et al. Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy. J Cardiovasc Magn Reson. 2021;23(1):1-13.

https://doi.org/10.1186/s12968-021-00803-7

Pérez-Carrillo L, Giménez-Escamilla I, Sánchez-Lázaro I, Triviño JC, Feijóo-Bandín S, Lago F et al. Alpha-cardiac actin serum expression levels detect acute cellular rejection in heart transplant patients. Transplantation. 2022:10.1097.

https://doi.org/10.1097/TP.0000000000004273

Downloads

Published

2023-02-16

How to Cite

Negargar, S., & Sadeghi, S. . (2023). Early Postoperative Cardiac Complications Following Heart Transplantation: Post-Heart Transplantation Complications. Galen Medical Journal, 12, e2701. https://doi.org/10.31661/gmj.v12i.2701

Issue

Section

Review Article